Navigation Links
TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men
Date:8/3/2009

Kronos Early Estrogen Prevention Study (KEEPS), will more fully address the issue of the benefits of menopausal HT in women close to the menopausal transition. Results from this study are not expected for several more years.

Another KLRI study, appearing in the Journal of Clinical Endocrinology and Metabolism and led by Marc Blackman of the Washington DC VA Medical Center, tests the effects of growth hormone (GH) therapy, both combined with sex steroids and alone, in healthy, ambulatory men and women over 65 years of age for a period of six months. The study found that GH caused insulin resistance (the body's inability to respond to and use the insulin it produces) to increase, yet it had a beneficial effect on lipids (molecules in the blood that include cholesterol and triglycerides).

"It's extremely unusual to analyze the effect of both growth hormone and sex steroids," said Harman.

This research is particularly interesting because the effects of GH therapy have not been studied extensively. The body naturally secretes growth hormones to fuel growth through childhood and maintain tissues and organs. Their use as an anti-aging therapy stems from the natural decrease of growth hormones secreted by the body as we reach middle age--replacing them with artificial GH, in theory, would slow the aging process. However, there is little evidence to suggest that it is effective.

Very few studies have tested the combined effects of GH and sex-steroids on glucose tolerance, elevated cholesterol and insulin sensitivity--changes in older adults that occur as a result of aging and that contribute to increased risk for cardiovascular disease. GH has been found to decrease total body and regional fat mass in older men, while sex-steroids have been reported to have positive effects on lipid (fat) concentrations in the body.

About Kronos Longevity Rese
'/>"/>

SOURCE Kronos Longevity Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
2. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
3. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
4. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
5. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
6. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
7. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
8. Obesity-Related Hormone is Higher in Children with Down Syndrome
9. Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
10. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
11. First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ire-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"...sentationofclinicaltrialdataonNGX426,theCompany,so...ntagonist,atthe12thInternationalConferenceontheMec...r20-21inSanFrancisco.TheresultsofthestudyledbyMark...eCenterforPainMedicineoftheUniversityofCaliforniaa...
(Date:11/23/2009)...ewswire-FirstCall/--NeurobiologicalTechnologies,In...ofdirectorshasdeclaredanextraordinarydividendof$0....,2009tostockholdersofrecordasofNovember30,2009.The...derapprovalofthedissolutionofNTIpursuanttoaplanofc...rdinarydividendof$0.75persharethatwaspaidtoshareho...
(Date:11/20/2009)...swire/ -- The United States Court of Appeals for ... ruling yesterday, approving a settlement in the l...utical litigation against AstraZeneca Pharmaceutic...gi-bin/prnh/20080317/AQM144LOGO ) ,, The ruling...urchased the pharmaceutical giant,s prostate cance...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 1HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 2HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 3Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2
...Mo.--(BUSINESS WIRE)--May 4, 2007 - New data have,...erosis (RRMS),patients treated with COPAXONE(R) (g...osuppression with mitoxantrone experienced a,90 pe...)-monitored,disease activity compared to their bas...ere sustained throughout the 24-month study,period...
...ngland, 4th May 2007 - CeNeS Pharmaceuticals plc,(...ompany, notes,the publication of an independent st... on its Phase II NMDA antagonist, CNS 5161. CeNeS,...r neuropathic,pain. The independent study builds o...CNS 5161. , In the study reported in ,Synapse, Dr...
Other Medicine Technology:Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
(Date:11/23/2009)... Women who store fat on their waist in middle age ...when they get older, reveals a new study from the ...ublished in the scientific journal Neurology . ,...is at greater risk of dying prematurely due to a h...nior lecturer at the Sahlgrenska Academy. "If they...
(Date:11/23/2009)... MAYWOOD, Il. -- A Loyola University Health System...tics is morbidly obese -- approximately 100 pounds... 62.4 percent of U.S. adults with Type 2 diabetes ...ong African American adults with Type 2 diabetes, ...obesity among people with diabetes is increasing a...
(Date:11/23/2009)... Alzheimer,s disease is caused by the build-up of ...iminating the protein has been the focus of almost...ting neurodegenerative condition. , But that may...l Aviv University,s Department of Physiology and P...nt research demonstrates that amyloid-beta is also...
(Date:11/23/2009)... Life-Science Focused Stra... of Marketing and Communication Professionals , ...23, 2009 -- LaVoie Group, a life science-focused s...at it has received the 2009 MarCom Gold Award in t...nd judged by the Association of Marketing and Comm...
(Date:11/23/2009)..., LOSANGELES,Nov.23/PRNewswire-FirstCall/--In...hatitsproprietarybrandsof MD@Hand ,target=,_blank,..., MD@Hand ,target=,_blank,title=, MD@Hand ,> MD@Ha...MD@Hand ,target=,_blank,title=, MD@Hand ,target=...k,title=, MD@Hand ,target=,_blank,title=, MD@Hand ...
Breaking Medicine News(10 mins):Health News:Diabetics show alarming increase in morbid obesity 2Health News:Upending textbook science on Alzheimer's disease 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7
...y conducted by Sue Bailey, professor of forensic c...f Central Lancashire it was found// that school gi... bad mothers. The researcher presented her stu...like that of their male counterparts. Mothers ...
... said it has received tentative approval by USFDA ... of 100mg, 150mg and 200mg strengths. // Thi...sine chewable in the world given by USFDA, Aurobin...AIDS Relief (PEPFAR), it added. The company m...
... Chernobyl disaster that took place two decades ag...dioactivity are not as harmful// as it is thought ...re exists a certain level of toleration or limit o... discussion in several countries. Mike Repac...
... provided a grant of $6 million for the Florida St...ch work for dyslexia in children.// The schedule ... of the symptom. The grant will fund the cre...e nation, represents the NIH's flagship research p...
...ticated test have found that any kind of exercise ... lead researcher, Todd M. Manini, an exercise phys..."There are plenty of reports out there saying that... team conducted a six-year study on 302 people bet...
...a lethal condition called aortic dissection (a tea...three years ago//. His death brought the focus on ... blood pressure and genetic disorders. Now, r...zation for its most serious form will still be ali...
Other Medicine News:Health News:Research Fund for FSU to Eradicate Dyslexia 2Health News:Physical Activity of any kind to Prolong Life 2Health News:Aortic Dissection - A Deadly Condition 2Health News:Aortic Dissection - A Deadly Condition 3Health News:Aortic Dissection - A Deadly Condition 4
Cervical Retractor
Scoville Cervical Disc Retractor
Cervical Retractor Handle - Small
Toothed Pituitary Rongeurs
Medicine Products: